Observation of the effect of carvedilol in congestive heart failure in patients with dilated cardiomyopathy
Liu Kai-chun
Abstract
Liu Kai-chun
Abstract
Objective:To investigate the clinical effect of carvedilol in the treatment of congestive heart failure(CHF) in patients with dilated cardiomyopathy(DCM).Methods:60 DCM patients with CHF were randomly divided into carvedilol group and control group on the basis of digitalis,diuretic,ACEI and nitro-glycerine treatment,with 30 cases in each group.The fraction shortening(FS),left ejection fraction(EF),strok volume(SV),left ventricular diastolic dimension(LVDD),interventricular septum(IVS) and left ventricular posterior wall(LVPW) in both groups were measured with echocardiography before and 4 months after treatment.Results:4 months after treatment,the cardiac funtion in both groups improved markedly,but that in carvedilol group improved more significantly compared with that in control group,such as LVDD(60.5±6.6 vs 67.3±6.1,P0.05),EF(47.8±9.7 vs 40.5±6.4,P0.05),and D/T(4±0.7 vs 4.5±0.5,P0.05).Conclusion:Carvedilol possesses protective effect on cardiac function and myocardium in DCM patients with CHF.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To investigate the clinical effect of carvedilol in the treatment of congestive heart failure(CHF) in patients with dilated cardiomyopathy(DCM).Methods:60 DCM patients with CHF were randomly divided into carvedilol group and control group on the basis of digitalis,diuretic,ACEI and nitro-glycerine treatment,with 30 cases in each group.The fraction shortening(FS),left ejection fraction(EF),strok volume(SV),left ventricular diastolic dimension(LVDD),interventricular septum(IVS) and left ventricular posterior wall(LVPW) in both groups were measured with echocardiography before and 4 months after treatment.Results:4 months after treatment,the cardiac funtion in both groups improved markedly,but that in carvedilol group improved more significantly compared with that in control group,such as LVDD(60.5±6.6 vs 67.3±6.1,P0.05),EF(47.8±9.7 vs 40.5±6.4,P0.05),and D/T(4±0.7 vs 4.5±0.5,P0.05).Conclusion:Carvedilol possesses protective effect on cardiac function and myocardium in DCM patients with CHF.
Key concepts: Medicine, Carvedilol, Cardiology, Ejection fraction, Dilated cardiomyopathy, Heart failure, Internal medicine, Interventricular septum